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progressors (NP) constituted those children who had HIV-1 infection for less than 10 years with CD4 cell count <500 cells/mm 3 . The time of onset of HIV infection was considered as the date of birth of the child, and the length of infection was the same as child's age. Clinical features and CD4 counts were documented for this study, and viral load was performed using Abbott m2000RT Real Time PCR assay. Genomic DNA was extracted from whole VOLUME 51 __ OCTOBER 15, 2014 CHAUDHURI, et al.
HOST GENETIC FACTORS AND HIV PROGRESSION blood using QIAmp DNA Blood Mini Kit (Qiagen, US). SDF1-3'A and CCR5-59029G genotypes were identified by PCR-based restriction followed by fragment length polymorphisms (PCR-RFLP) using MspI and BsaBI. CCR5-Δ32 was amplified by PCR using the primers described previously [8] . HLA-B*57 and B*27 allele polymorphisms were determined by SSPGo-HLA Typing Kits (Biofortuna, Bromborough, UK) as per manufacturer's instructions.
RESULTS
Among the 165 children who were initially screened, we identified 6% LTNPs and 5% SPs. We also included 12 NPs, and the final study sample consisted of 30 children (14 males The clinical features and allelic distribution of ARGs among the three groups is presented in Table I . None of the children had CCR5-Δ32 deletion; all had wild-type CCR5. Among the SPs and LTNPs together (collectively called "long term survivors" (LTS)), the SDF1-3'A allele was found either in the heterozygous or homozygous form in 44% (8/18). Among NPs, it was found in 25% (3/12) (P=0.279), Similarly, the CCR5-59029G allele was found in 89% (16/18) among LTS and 92% (11/12) among NPs (P=0.804). The HLA-B*57-positive SP was also heterozygous for SDF1-3'A and CCR5-59029G while the HLA-B*57-positive LTNP was homozygous for SDF1-3'A and heterozygous for CCR5-59029G. The HLA-B*27-positive LTNP was also heterozygous for CCR5-59029G.
DISCUSSION
The progression to AIDS was observed to vary widely in our HIV-1-infected pediatric cohort. It is noteworthy that a tenth of all the children being followed in the clinic belonged to the LTNP or slow progressor category.
The prevalence of LTNPs has been reported to be 3% in children of Spanish and Italian origin [9] , and 9% in children of Italian origin [10] . These studies demonstrated the occurrence of known ARGs (CCR5-Δ32 and SDF1-3'A) among LTNPs at low frequencies. Previous studies in India have analyzed the prevalence of ARGs among exposed seronegative HIV-1 populations and healthy controls [6, 11] . A study from a French cohort of adults previously reported that the CCR5-D32 and SDF1-3'A along with HLA-genotypes in combination, portray the synergistic effects of ARGs in disease progression [12] . HLA class I alleles have been closely associated with immune control in HIV among humans [13] . The observation that HIV-infected HLA-B*27-positive individuals can mount strong cytotoxic T lymphocyte (CTL) responses against the immunodominant epitope showed that specific HLA class I alleles can influence the outcome of HIV infection [14] . There is also a gag epitope (corresponding to the gag amino acids 240-249) which is the main target of the acute CD8+T-cell response in HIVinfected subjects who have the HLA-B*57 allele [15] .
Our study findings are limited by a cross-sectional design and small sample size. The host genetic studies were also restricted to a small number of factors; other host genetic factors are yet to be studied in this population.
Our study highlights the proportion of Indian children with slow disease progression among the cohort of children living with HIV. These preliminary results of host genetic studies suggest an association between known ARGs, as well as a possible combined effect of host factors such as chemokine-receptors and their ligands, and HLAclass molecules on the outcome of disease progression. A larger sample size and a more extensive list of factors, including host chemokine co-receptor polymorphisms and viral alterations associated with HIV-1 disease nonprogression may reveal better insight into the protective correlates among the Indian HIV-1 population.
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